FRom data collected in a previous inquiry (DoR and Hill, 1950) 
RESULTS.
The combined purgative experience of the gastro-intestinal cancer patients and the non-gastro-intestinal patients was tabulated in four age-groupings for males and females separately (Table I) , and utilised to obtain the purgative consumption " expected " if both groups of patients had been subject to the same overall purgative rates (Table II) while the " expected " number was 206). The differences, however, were such as might well be due to chance alone. A simflar trend towards heavier usage was found for both cancer of the large bowel and cancer of the stomach when these groups were considerecl separately, being more marked for male patients with cancer of the large bowel and for females with cancer of the stomach. Again however, the differences noted-while consistent and in the same directiondid not reach a statistically significant level.
Following .he comparison of overaR purgative usage, an attempt was made to discover whether the experience of the gastro-intestinal cancer and non-gastrointestinal groups differed when specific purgatives were considered separately. As a first step crude rat-es expressing the usage of 14 purgatives were calculatecl for the four disease groups: cancer of the large bowel, cancer of the stomach, cancer of the lung, and non-gastro-intestinal diseases other than cancer (Table  IV) . Study of these rates suggested that for only three purgatives-liquid (X2 -7.21 , n -2, P = 0 03),-there was no significant difference between the experience of patients with cancer of the stomach and those suffering from a non-gastro-intestinal complaint. The third comparison, relating to the usage of Beecham's pills, showed no significant excess amongst the gastro-intestinal patients when considered collectively, or on breakdown to cancer of the large bowel (X2 -4.36, n -2, P > 0.1) and cancer of the stomach (X2 x 3.52, n = 2, P > 0.1). Thus after due allowance for the differing age and sex structures of the two populations, it would appear that only in the use of liquid paraffin does there remain any worthwhile evidence in support of the apparent excess being real. Examination of the ratios between observed and expected numbers in the three categories of liquid paraffin usage i.e., "never," "occasionally" and "often," supports this evidence. The ratios are respectively 0.97, 1.35 and 1.42, and they thus display a biological gradient of increasing "excess" with heavier usage of liquid paraffin. Study of the duration of purgative medication amongst patients taking liquid paraffin "often" also suggested a similar pattern (Table VII) . Comparison between gastro-intestinal cancer and non-gastro-intestinal groups showed a higher proportion of patients in the gastro-intestinal cancer group had been taking liquid paraffin for as many as 20 years, and conversely there was a highel proportion of non-gastro-intestinal patients whose purgative medication extended over a period of less than 10 years. This difference, however, may be due to the differing age and sex structure of the two groups; the relatively small numbers available did not permit any useful comparison within separate age and sex groupings. DISCUSSION. Liquid paraffin is defined by the 'British Pharmacopoeia' as "a mixture of liquid hydrocarbons obtained from petroleum." According to Wood and Osol (1943) it "is made by distilling the residuary liquid boiling between 330°C. and 390°C. obtained after removing the lighter hydrocarbons from petroleum. It is purified and decolorized by first treating it with sulfuric acid and then with caustic soda and passing it while hot through animal charcoal. By cooling some solid paraffins will separate; the liquid is then redistilled, and the portion boiling below 360°C., rejected." In view of the known carcinogenic activity of crude petroleum, much attention has been paid to the possibility that liquid paraffin may contain carcinogenic fractions. The process of purification is likely to remove the greater part, it not all, of the polycyclic compounds initially present, but on at least one occasion samples of liquid paraffin offered for human consumption contained fluolescent substances (Trevan, personal communication) and the extent to which the original oil is purified is likely to vary from time to time and from manufacturer to manufacturer.
Tests on animals have always proved negative (Twort and Ing, 1928; Wood 1930) and liquid paraffin has been used as a vehicle for testing the carcinogenicity of other substances. These observations do not, however, entirely exclude the possibility that it may play some part in human carcinogenesis, either as a very weak carcinogen or in an ancillary role as a co-carcinogen or an accelerator.
The present data suggest that liquid paraffin may play such a part in a small proportion of cases of gastro-intestinal cancer in man. They do not prove it has such an effect. The data were obtained incidentally in the course of an investigation which was primarily concerned with the study of another type of cancer and more detailed and more accurate information from a larger number of cases is necessary before much weight can be attached to them. Moreover even if the basic data are considered to be sufficiently reliable, they are open to the interpietation that the usage of liquid paraffin is itself correlated with some factor which predisposes to the development of cancer of the stomach and large bowel. In this respect it is necessary, for example, to test whether the use of liquid paraffin may not be commoner in one or other social class or be prescribed because of the development of some other lesion of the gastro-intestinal tract, which predisposes to the development of cancer.
Since the period 1905-1910, when the medicinal use of liquid paraffin was first introduced at all extensively, there has been no important increase in the mortality from cancer of the stomach and large bowel; in recent years the mortality has even slightly decreased. Furthermore, liquid paraffin is used more commonly by women, yet the mortality from cancer of the stomach and large bowel is greater in men (in 1952, the crude mortality rate was 17 per cent higher in men than in women). It is, therefore, unlikely that liquid paraffin could be an important cause of either condition. Such differences in mortality are, however, not necessarily in conflict with the results of the present study, since if the data are interpreted to mean that liquid paraffin does contribute to the carcinogenic process, they also imply that the proportion of cases in which it is concerned is of the order of only 5 per cent.
SUMMARY.
The purgative histories of 614 patients diagnosed as having a gastro-intestinal cancer were compared with similar histories of 1313 patients who were suffering from diseases other than gastro-intestinal. No significant difference was discovered between the groups as regards their overall use of purgatives. Study of individual purgatives revealed an appreciable excess amongst gastro-intestinal cancer patients only in the use of liquid paraffin.
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